HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Hormone suppression therapy in benign nodular goiter].

Abstract
Nodular goitre was detected in as many as 21 - 27% of the adult population in a non-endemic area. The most frequent therapeutic procedure is suppressive treatment with thyroxine. The author analyzes the results of prospective randomized, placebo controlled studies, which focused attention on the effectiveness of suppressive treatment. In the majority an inadequate effect was recorded. In the conclusion the author suggests an algorithm of suppressive treatment of nodular goitre and conditions after goitrectomy on account of nodular goitre.
AuthorsZ Málek
JournalVnitrni lekarstvi (Vnitr Lek) Vol. 42 Issue 9 Pg. 610-4 (Sep 1996) ISSN: 0042-773X [Print] Czech Republic
Vernacular TitleHormonálna supresívna liecba benígnej uzlovej strumy.
PMID8984767 (Publication Type: English Abstract, Journal Article, Meta-Analysis)
Chemical References
  • Thyrotropin
  • Thyroxine
Topics
  • Adult
  • Goiter, Nodular (drug therapy, metabolism)
  • Humans
  • Randomized Controlled Trials as Topic
  • Thyrotropin (metabolism)
  • Thyroxine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: